{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:51:35Z","timestamp":1790628695811,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bmcl.2025.130108","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T17:28:41Z","timestamp":1737653321000},"page":"130108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Novel isoxazole thiophene-containing compounds active against Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"119","author":[{"given":"Gabrielle","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Tolentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paridhi","family":"Sukheja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Case W.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab K.","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130108_b0005","unstructured":"WHO, Global Tuberculosis Report 2022. https:\/\/www.who.int\/teams\/globaltuberculosis-programme\/tb-reports\/global-tuberculosis-report-2022 Retrieved 28 April 2023."},{"key":"10.1016\/j.bmcl.2025.130108_b0010","doi-asserted-by":"crossref","unstructured":"The Lancet Infectious Diseases. Tuberculosis at the United Nations: a missed chance. Lancet 568 Infect Dis 18, 1161 (2018).","DOI":"10.1016\/S1473-3099(18)30623-6"},{"key":"10.1016\/j.bmcl.2025.130108_b0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7861\/clinmedicine.14-3-279","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges","volume":"14","author":"G\u00fcnthe","year":"2014","journal-title":"Clin Med J"},{"key":"10.1016\/j.bmcl.2025.130108_b0020","unstructured":"Global Tuberculosis Report 2022. https:\/\/www.who.int\/teams\/global-tuberculosis-573 programme\/tb-reports\/global-tuberculosis-report-2022 (2022)."},{"key":"10.1016\/j.bmcl.2025.130108_b0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/mmi.13701","article-title":"Chemical activation of adenylyl cyclase Rv1625c inhibits growth of Mycobacterium tuberculosis on cholesterol and modulates intramacrophage signaling","volume":"105","author":"Johnson","year":"2017","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bmcl.2025.130108_b0030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.tim.2024.01.008","article-title":"Exploiting cAMP signaling in Mycobacterium tuberculosis for drug discovery","volume":"32","author":"Kathayat","year":"2024","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bmcl.2025.130108_b0035","doi-asserted-by":"crossref","first-page":"e01294","DOI":"10.1128\/aac.01294-22","article-title":"Cyclic AMP-Mediated Inhibition of Cholesterol Catabolism in Mycobacterium tuberculosis by the Novel Drug Candidate GSK2556286","volume":"67","author":"Brown","year":"2023","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.bmcl.2025.130108_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009862","article-title":"Pharmacological and genetic activation of cAMP synthesis disrupts cholesterol utilization in Mycobacterium tuberculosis","volume":"18","author":"Wilburn","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmcl.2025.130108_b0045","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1504022112","article-title":"Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis","author":"Harbut","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.bmcl.2025.130108_b0050","first-page":"E2510","article-title":"Identification of a small molecule with activity against drug-resistant and persistent tuberculosis","author":"Wang","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.bmcl.2025.130108_b0055","doi-asserted-by":"crossref","first-page":"13011","DOI":"10.1002\/anie.201707324","article-title":"Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes","volume":"56","author":"Liu","year":"2017","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2025.130108_b0060","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1002\/ange.201800260","article-title":"Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity","volume":"130","author":"Harbut","year":"2018","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2025.130108_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129596","article-title":"Synthesis and structure\u2013activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents","volume":"98","author":"Yang","year":"2024","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130108_b0070","first-page":"317","article-title":"Sterilising action of pyrazinamide in models of dormant 623 and rifampicin-tolerant Mycobacterium tuberculosis","author":"Hu","year":"2006","journal-title":"Int J Tuberc. Lung Dis off J Int Union Tuberc Lung Dis"},{"key":"10.1016\/j.bmcl.2025.130108_b0075","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Bedaquiline, pretomanid and linezolid for treatment of extensively drug resistant, intolerant or non-responsive multidrug resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2025.130108_b0080","doi-asserted-by":"crossref","unstructured":"D. Gramec, L. P. Masic, M. S. Dolenc. Bioactivation Potential of Thiophene-Containing Drugs. Chem Res Toxicol 2014, 27, 1344\u22121358. dx.10.1021\/tx500134g.","DOI":"10.1021\/tx500134g"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T03:12:42Z","timestamp":1740453162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":16,"alternative-id":["S0960894X25000174"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130108","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel isoxazole thiophene-containing compounds active against Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"130108"}}